PTSD and Akathisia

Information presented on this page  may be triggering for some people. If you are having suicidal thoughts, contact the National Suicide Prevention Lifeline at 988 for support and assistance from a trained counselor. If you or a loved one are in immediate danger, call 911.

PTSD and akathisia are interconnected conditions that can significantly impact mental health.

Understanding Akathisia

• Akathisia is a neurological      disorder characterized by severe agitation and an inability to remain      still, often caused by certain medications, particularly antipsychotics.
• Symptoms can be distressing and      may lead to feelings of terror, which can exacerbate mental health issues.

Connection to PTSD

• Individuals experiencing      akathisia may develop PTSD due to the distressing nature of their      symptoms.
• The overwhelming agitation and      discomfort can create a traumatic experience, leading to anxiety and      flashbacks associated with PTSD.

Management Strategies

• Treatment for akathisia often      involves adjusting medication or adding other medications to alleviate      symptoms.
• Addressing both akathisia and      PTSD may require a comprehensive approach, including therapy and      medication management.

Antipsychotic-induced akathisia (AIA) occurs in 14% to 35% of patients treated with antipsychotics and is associated with increased suicide and decreased adherence in patients with schizophrenia. However, no comprehensive review and network meta-analysis has been conducted to compare the efficacy of treatments for AIA.

PTSD and Akathisia Impact on the Brain
Both PTSD (Post-Traumatic Stress Disorder) and akathisia can lead to significant changes in brain function and structure. Here’s a brief overview of their effects:

PTSD Effects on the Brain

• Amygdala: Heightened activity, leading to      increased fear responses.
• Hippocampus: Reduced volume, affecting      memory and learning.
• Prefrontal Cortex: Impaired functioning, which can      hinder emotional regulation and decision-making.

Akathisia Effects on the Brain

• Dopamine Pathways: Dysregulation in dopamine      transmission, often linked to medications affecting these pathways.
• Cortex and Basal Ganglia: Altered activity can lead to      restlessness and anxiety

Akathisia can lead to PTSD in some individuals.
Akathisia is a distressing neurological disorder characterized by severe agitation and an inability to remain still, often caused by medications, particularly antipsychotics. The intense discomfort and anxiety associated with akathisia can be traumatic, potentially resulting in post-traumatic stress disorder (PTSD) for some individuals.

Symptoms and Impact

• Agitation and Restlessness:      Individuals may experience overwhelming restlessness, leading to      significant distress.
• Trauma Response: The severity of      symptoms can create a traumatic experience, which may manifest as PTSD.
• Support Needs: Many affected      individuals find it beneficial to seek counseling or support groups to      address both akathisia and its psychological impacts.

Understanding the Connection

• Medication-Induced: Akathisia is      primarily linked to prescribed medications, making awareness and      management crucial.
• Long-Term Effects: Some      individuals report lasting psychological effects even after akathisia      symptoms subside.

In summary, while akathisia is primarily a physical condition, its psychological ramifications can lead to PTSD, necessitating comprehensive treatment approaches.

Akathisia is an inability to remain physically still. It’s a movement disorder that’s linked to certain types of medications, especially antipsychotic medications. People with akathisia feel an intense and uncontrollable need to move — mainly, their lower body.

Akathisia is a neuropsychiatric syndrome and movement disorder that makes it difficult to sit or remain still due to an inner restlessness. The name comes from the Greek word “akathemi,” which means “inability to sit.”

Akathisia is associated with the use of certain types of medications, especially antipsychotic (neuroleptic) medications. A few health conditions have also been linked to akathisia, including Parkinson’s disease.

A person with akathisia experiences an intense sensation of unease or an inner restlessness. This results in a compulsion to move — usually in their lower limbs. In most cases, the movement is repetitive. This uncontrollable need to move can cause extreme distress.

Healthcare providers classify akathisia in a few ways based on its time of onset and duration, including:

· Acute akathisia: When akathisia develops during the early days of starting a medication, usually antipsychotic medication, or shortly after an increase in dosage, it’s considered acute akathisia. It usually lasts for fewer than six months.

· Chronic akathisia: When akathisia signs and symptoms last for more than six months, it’s considered chronic akathisia. Chronic akathisia can last for several months or even years.

· Tardive akathisia: When akathisia has a delayed onset after starting certain medications or increasing the dosage — usually more than three months — it’s considered tardive akathisia. It’s often associated with tardive dyskinesia.

· Withdrawal akathisia: Akathisia may arise following the reduction of dosage or stopping the use of certain medications. This is considered withdrawal akathisia.

· People with akathisia typically describe a feeling of restlessness with a strong, uncontrollable need to move. They describe nervousness and an inability to relax.

· They may also have a mounting sense of tension when they need to stand still, such as when waiting in line.

· Inner restlessness often causes extreme anxiety and distress in people with akathisia. Chronic cases of akathisia have been associated with a high risk of self-harm or suicidal behavior.

· If you’re having suicidal thoughts or thoughts of harming yourself, it’s important to seek immediate medical care.

Scientists don’t know the exact cause of akathisia, but they think it’s due to certain medications blocking dopamine receptors in your brain. Dopamine is a neurotransmitter that plays a role in many important body functions, including movement. The blocking ultimately results in unwanted involuntary movements.

Several medications are associated with akathisia, including:

· Antipsychotic (neuroleptic) medications.

· Antidepressants.

· Other medications.

Certain health conditions are also associated with akathisia, including:

· Parkinson’s disease.

· Encephalitis (brain inflammation).

· Traumatic brain injury (TBI).

· The prognosis (outlook) of akathisia is generally good if it’s diagnosed early and the drug causing it is stopped (if possible).

· If akathisia is left untreated, it generally causes a poor quality of life. Many people with akathisia develop severe anxiety and dysphoria, and it can even lead to suicidal ideations (thoughts).

· If you’re experiencing suicidal ideation, it’s important to seek immediate care. Call 911 or the National Suicide Prevention Lifeline at 800.273.8255. Someone will be available to talk with you 24 hours a day, seven days a week.

Movement disorders represent among the most distressing and clinically significant side effects of antipsychotic medications. This comprehensive review examines the manifestations, etiology, pathophysiology, and management strategies for akathisia and tardive dyskinesia—two of the most common antipsychotic-induced movement disorders affecting clinical practice. Akathisia, derived from the Greek "a" (without) and "kathisis" (sitting), represents a profound subjective sense of inner restlessness, agitation, and inability to sit still or remain motionless. Unlike simple psychomotor agitation, akathisia is characterized by an intense dysphoric quality—patients describe a compelling, often irresistible urge to move despite conscious attempts to remain stationary.

The clinical manifestations of akathisia present across multiple domains:

· Subjective symptoms: Intense inner restlessness, anxiety, dysphoria, tension, and sense of unbearable discomfort

· Objective motor signs:Constant fidgeting, inability to sit for more than brief periods, pacing, rocking, crossing and uncrossing legs, repetitive hand movements

· Temporal pattern:Typically emerges within days to weeks of antipsychotic initiation or dose escalation

· Psychological impact: Often leads to medication non-compliance, worsening of underlying psychiatric condition, and increased suicide risk

·  

Acute akathisia typically emerges within days to weeks of antipsychotic initiation or dose escalation and generally responds well to pharmacological intervention.

Management of Tardive Dyskinesia

Tardive dyskinesia management presents greater challenges than acute akathisia due to the established neurodegeneration. Treatment goals focus on symptom reduction, preventing progression, and improving quality of life.

· Movement disorders represent significant sources of morbidity and medication non-compliance; proactive assessment and management are essential

· Akathisia typically responds excellently to beta-blockers or benzodiazepines; consider antipsychotic adjustment if medications ineffective

· Tardive dyskinesia requires early detection through regular AIMS assessment; preventive strategies are more effective than treating established disease

· Valbenazine and deutetrabenazine represent the current evidence-based pharmacological approach to tardive dyskinesia management

· Clozapine remains unique among antipsychotics in potentially improving tardive dyskinesia while maintaining antipsychotic efficacy

· Regular monitoring with standardized assessment scales (BARS for akathisia, AIMS for tardive dyskinesia) should be integrated into routine clinical practice

· Individual susceptibility to movement disorders varies significantly; genetic screening may facilitate personalized prevention strategies

www.akathisiaalliance.org

Post-traumatic stress disorder (PTSD) is a mental health condition that's caused by an extremely stressful or terrifying event — either being part of it or witnessing it. Symptoms may include flashbacks, nightmares, severe anxiety and uncontrollable thoughts about the event.

Most people who go through traumatic events may have a hard time adjusting and coping for a short time. But with time and by taking good care of themselves, they usually get better. If the symptoms get worse, last for months or years, and affect their ability to function daily, they may have PTSD.

Trauma doesn’t always end when the danger is over. For many, the body and brain remain locked in survival mode, long after the traumatic event has passed. This is the painful reality of post-traumatic stress disorder (PTSD), a condition marked by the brain’s inability to properly process and resolve trauma, leaving individuals emotionally stuck in fear, guilt, or shame.

Getting treatment after PTSD symptoms arise can be very important to ease symptoms and help people function better.

Posttraumatic stress disorder (PTSD) is a condition caused by seeing or being threatened with death, significant injury, 

or sexual assault. PTSD is widespread after a traumatic experience and is one of the significant health issues linked with 

comorbidity, functional impairment, and increased mortality with suicidal ideations and attempts. 

Post-Traumatic Stress Disorder (PTSD) profoundly disrupts daily life, impacting everything from sleepand relationships to work and overall well-being; its effects are multifaceted and often debilitating. It fundamentally alters how individuals perceive and interact with the world around them, leading to significant functional impairments.

Statistical Manual of Mental Disorders (DSM-5) has classified PTSD as a Trauma- and Stress-related Disorder. 

PTSD symptoms include re-experiencing the horrific incident again, intrusive thoughts, nightmares, flashbacks, 

dissociation (detachment from oneself or reality), and severe negative emotions (sadness, guilt) and physiological 

reactions when exposed to the painful reminder. Additionally, sleep and attention issues, irritability, increased 

sensitivity, enhanced startle response, hypervigilance, and avoidance of stressful stimuli ensue. Social, vocational, and 

other aspects of functioning are significantly impaired. However, the symptoms of PTSD and acute stress disorder 

coincide. For a patient to be diagnosed with PTSD, the symptoms must last longer than one month.

For any comments that you would like to have added to this page, contact Tim at timbuettner48@gmail.com   or at                405-900-1141